Ginkgo Bioworks Holdings (DNABW) Total Non-Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings has reported Total Non-Current Liabilities for 7 years, with the latest figure at $568.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 9.9% year-over-year to $568.2 million; the trailing twelve-month figure through Mar 2026 stood at $568.2 million (down 9.9% YoY), and the FY2025 full-year result was $588.2 million, down 8.78% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $568.2 million, down from $588.2 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $792.2 million in Q4 2022, with the low at $391.1 million in Q2 2022.
• Historically, Total Non-Current Liabilities has averaged $615.9 million across 5 years, with a median of $612.2 million in 2025.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 535.75% — and 2023, when it slumped 31.36%.
• Ginkgo Bioworks Holdings' Total Non-Current Liabilities stood at $792.2 million in 2022, then plunged by 31.36% to $543.8 million in 2023, then climbed by 18.59% to $644.8 million in 2024, then declined by 8.78% to $588.2 million in 2025, then slipped by 3.41% to $568.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $568.2 million (Q1 2026), $588.2 million (Q4 2025), and $612.2 million (Q3 2025), per Business Quant data.